HIV-1-infection
312
37
63
158
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
53 trials with published results (17%)
Research Maturity
158 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.1%
16 terminated out of 312 trials
90.8%
+4.2% vs benchmark
25%
77 trials in Phase 3/4
34%
53 of 158 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 158 completed trials
Clinical Trials (312)
Addressing Barriers to Anti-hypertensive Medication Adherence Among PLWH Who Have Achieved Viral Suppression
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance
A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
Efficacy and Safety of Doravirine in the Rapid Initiation
2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial
Immuno-virological Evaluation of Persons Living With HIV (PLWH)
Dolutegravir/Lamivudine in Treatment-Naïve Pregnant Women
Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
IGHID 12230 - An Implementation Trial of an Experiential Brief Alcohol Intervention for HIV Prevention
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
Improving Coronary Vascular Health in Women
Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers
HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
Expedited Partner Therapy and the HIV Prevention Cascade